“…Based on the literature, most isolated bacteria possessed high antibiotic resistance to common antibiotics and various studies on the prospective antibiotic consumption during the first wave of the COVID‐19 pandemic described changing trends over time 71,72 . Several investigations have been performed to assess the likely impact of the SARS‐CoV‐2 pandemic on different facets of life, health, and underlying health system parameters such as costs, antibiotic resistance, physiological effects, and possible interaction with other diseases 16–18,29,30,35,48,49,53,54 . There is still no specific, completely safe, and appropriate drug, method, or vaccine for the treatment or prevention of CL, as well as the occurrence of secondary infections at the wound site and the need to take other antibiotics, along with the emergence of resistance to anti‐leishmanial and antibacterial agents, makes the treatment of this infection more complicated 73–79 .…”